Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Park Medi World Ltd (PARKHOSPS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544645 NSE: PARKHOSPS Hospital & Healthcare Services | Small Cap | Park Medi World Share Price
₹286.45 0.80 (0.28%)
As on 25-Sep'26 16:59
Park Medi World Ltd (PARKHOSPS)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544645 NSE: PARKHOSPS Hospital & Healthcare Services | Small Cap | Park Medi World Share Price
₹286.45 0.80 (0.28%)
As on 25-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹12,373 Cr.
Current Price
₹286.5
52-Week Low / High
₹138 / 305
TTM EPS
₹6
TTM Sales
₹1,679 Cr.
Book Value per Share
₹48.6
P/E Ratio
47.93
Lower than its 5-year historical median
Industry PE
99.7
Price to Book (P/B)
5.90
Lower than its 5-year historical median
Price to Sales (P/S)
7.37
Lower than its 5-year historical median
EV/EBITDA
25.46
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
17.94%
Return on Capital Employed (ROCE)
21.30%
Return on Assets (ROA)
11.16%
Operating Profit Margin
26.6%
Net Profit Margin
16.29%
Gross Profit Margin
24.8%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
40.83%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
19.97%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
26.98%
Asset Quality
Promoter Holding
82.89%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹2,012 Cr.
Equity
₹86.4 Cr.
Face Value
₹2
All Time Low / High
₹138.15 / 305.25
Check Before You Invest
Quality
Very GoodValuation
Somewhat OvervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Park Medi World Ltd a good quality company?
Park Medi World Ltd is a good quality company, based on a consistently good multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Park Medi World Ltd performance compare with that of its Peers?
Revenue growth of Park Medi World Ltd vs industry peers?
Park Medi World Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Park Medi World Ltd?
Promoters hold 82.89% of the Park Medi World Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Park Medi World Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Park Medi World Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good
Value Creation ⓘ
| Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|
| ROCE % ⓘ | 16.6% | 11.6% | 11.8% | 8.5% | 10.2% | - |
| Value Creation Index ⓘ | 0.2 | -0.1 | -0.1 | -0.4 | -0.2 | - |
Growth Parameters ⓘ |
||||||
| Sales ⓘ | 110 | 102 | 89.6 | 91.6 | 129 | 129 |
| Sales YoY Gr. | - | -6.8% | -12.6% | 2.3% | 40.8% | - |
| Adj EPS ⓘ | 0.2 | 0.2 | 0.2 | 0.2 | 0.9 | 0.9 |
| YoY Gr. | - | -13.6% | 5.3% | -5% | 347.4% | - |
| BVPS (₹) ⓘ | 2.5 | 2.6 | 2.8 | 3 | 19.9 | 19.9 |
| Adj Net Profit ⓘ | 8.4 | 7.1 | 7.5 | 7.2 | 36.6 | 37 |
| Cash Flow from Ops. ⓘ | 29.5 | 45.4 | 48.1 | 4.7 | 17.4 | - |
| Debt/CF from Ops. ⓘ | 3.3 | 2.5 | 2.6 | 33.9 | 0.6 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | 8% | 40.8% | ||||
| Adj EPS ⓘ | NA | NA | 64.8% | 347.4% | ||||
| BVPSⓘ | NA | NA | 96.9% | 570.4% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 8.6 | 7.2 | 7.3 | 6.6 | 7.5 | 4.3 |
| Op. Profit Mgn % ⓘ | 18.8 | 23.4 | 28.8 | 26.4 | 40.7 | 26.5 |
| Net Profit Mgn % ⓘ | 7.6 | 6.9 | 8.4 | 7.9 | 28.4 | 28.5 |
| Debt to Equity ⓘ | 1 | 1.1 | 1.2 | 1.4 | 0 | - |
| Working Cap Days ⓘ | 0 | 294 | 235 | 178 | 447 | 281 |
| Cash Conv. Cycle ⓘ | 0 | 84 | 33 | 14 | -1 | 246 |
Valuation of Park Medi World - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Sales | 1,084 | 1,255 | 1,231 | 1,394 | 1,679 |
| Operating Expenses ⓘ + | 740 | 864 | 919 | 1,022 | 1,233 |
| Operating Profit ⓘ | 344 | 391 | 312 | 372 | 446 |
| Operating Profit Margin (%) | 31.8% | 31.2% | 25.3% | 26.7% | 26.6% |
| Other Income ⓘ + | 10 | 18 | 32 | 32 | 32 |
| Interest ⓘ | 40 | 51 | 72 | 62 | 61 |
| Depreciation ⓘ | 35 | 41 | 51 | 57 | 62 |
| Profit Before Tax ⓘ | 278 | 315 | 218 | 286 | 355 |
| Tax ⓘ | 79 | 87 | 66 | 70 | 81 |
| Profit After Tax | 199 | 228 | 152 | 215 | 274 |
| PAT Margin (%) | 18.4% | 18.2% | 12.4% | 15.5% | 16.3% |
| Adjusted EPS (₹) | 4.7 | 5.7 | 4.0 | 5.3 | 6.0 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 457 | 687 | 883 | 1,052 | 2,022 | ||||||
| Debt + | 448 | 474 | 550 | 549 | 219 | ||||||
| Minority Interest | 87 | 43 | 53 | 67 | 82 | ||||||
| Trade Payables | 44 | 60 | 90 | 136 | 109 | ||||||
| Others Liabilities ⓘ | 257 | 329 | 330 | 312 | 354 | ||||||
| Total Liabilities ⓘ | 1,293 | 1,593 | 1,906 | 2,115 | 2,786 | ||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 458 | 536 | 837 | 890 | 1,309 | ||||||
| CWIP ⓘ | 29 | 5 | 32 | 37 | 123 | ||||||
| Investments ⓘ | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventories | 6 | 2 | 2 | 3 | 3 | ||||||
| Trade Receivables | 449 | 576 | 511 | 614 | 593 | ||||||
| Cash Equivalents | 192 | 203 | 390 | 361 | 431 | ||||||
| Others Assets ⓘ | 159 | 272 | 134 | 211 | 326 | ||||||
| Total Assets ⓘ | 1,293 | 1,593 | 1,906 | 2,115 | 2,786 | ||||||
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 155 | 199 | 361 | 215 | 329 |
| Cash Flow From Investing Activity ⓘ + | -248 | -234 | -255 | -100 | -333 |
| Cash Flow From Financing Activity ⓘ + | 163 | 1 | -130 | -89 | 121 |
| Net Cash Flow ⓘ | 70 | -34 | -23 | 26 | 116 |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 44.82 | 40.77 | 19.67 | 22.55 | 17.94 | |||||
| ROCE (%) | 33.62 | 33.59 | 21.2 | 21.95 | 21.3 | |||||
| Asset Turnover Ratio | 0.84 | 0.87 | 0.7 | 0.69 | 0.69 | |||||
| PAT to CFO Conversion(x) | 0.78 | 0.87 | 2.38 | 1 | 1.2 | |||||
| Working Capital Days | ||||||||||
| Receivable Days | 151.20 | 149.20 | 161.20 | 147.30 | 131.20 | |||||
| Inventory Days | 2 | 1.10 | 0.60 | 0.60 | 0.60 | |||||
| Payable Days | 101.20 | 95 | 110.70 | 146.50 | 151.20 | |||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Park Medi World Ltd FAQs
The current trading price of Park Medi World on 25-Sep-2026 16:59 is ₹286.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Park Medi World stood at ₹12,372.7 Cr
The latest P/E ratio of Park Medi World as of 24-Sep-2026 is 337.9.
The latest P/B ratio of Park Medi World as of 24-Sep-2026 is 14.37.
The 52-week high of Park Medi World is ₹305.2 and the 52-week low is ₹138.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Park Medi World is ₹129 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Park Medi World Ltd is a good quality company.
The key valuation ratios of Park Medi World Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Park Medi World Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Park Medi World Ltd
Park Medi World was incorporated in New Delhi as ‘Park Medi World Private Limited’ as a private limited company on January 20, 2011. Subsequently, the company was converted to a public limited company and the name of the company has been changed to the present name, ‘Park Medi World Limited’, pursuant to a resolution passed by the board on November 15, 2024 and by the shareholders on November 18, 2024.
The company is one of the largest private hospital chains in North India. It offers multiple super specialty and specialty services, including internal medicine, neurology, urology, gastroentereology, general surgery, orthopedics and oncology. It operates a network of NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which some hospitals are also NABL accredited. The company has adopted a cluster-based approach to grow its network of hospitals leveraging the benefits of proximity between its hospitals leading to operational efficiencies and enabling it to benefit from economies of scale.
In order to ensure that its services remain affordable, the company actively pursue several strategic measures to manage its operating costs. These include employing modern medical technology to reduce recovery time, employing full-time doctors and consultants, nurses and medical staff, maintaining strong relationships with its vendors and leveraging economies of scale from its existing network. The company is led by its founder and Chairman Ajit Gupta, whose leadership and deep understanding of the healthcare landscape in India has laid the foundation for the company’s growth.
Business area of the company
The company, along with its subsidiaries, is in the business of owning, managing and running medical facilities in order to provide comprehensive services and to undertake research including clinical research and development work required to promote, assist or engage in setting up hospitals.
Services of the company
- Internal Medicine
- Neurology
- Urology
- Gastroenterology
- Cardiology
- General Surgery
- Orthopedic
- Oncology
- Other specialty service
Awards, accreditations and recognition
- 2017: Indian Excellence Award for ‘Best Multi-Specialty Hospital in Delhi-NCR and Haryana’ in ‘Healthcare & Business Sector’ was awarded to Park Hospital.
- 2019: Healthcare Leadership Award for ‘Best Multi Super Speciality Hospital’ was awarded to Park Hospital, Gurgaon.
- 2019: Award for ‘Most Valuable and Admirable Hospital’ was awarded to Park group of Hospitals by ET Now.
History and milestones
- 2011: Incorporation of the company on January 20, 2011.
- 2011: Took over the running proprietorship business of Park Sunil Hospital, Delhi and/or Park Hospital, New Delhi from one of the Promoters, Ajit Gupta.
- 2011: The company acquired Aggarwal Hospitals and Research Services Private Limited.
- 2017: The company’s subsidiary, Park Medicenters acquired DMR Hospitals Private Limited.
- 2020: The company acquired Blue Heavens Health Care Private Limited.
- 2020: The company’s subsidiary, Kailash Super-Speciality Hospital Private Limited acquired 100% running business of ‘Kailash Hospital Behror’.
- 2021: The company acquired Umkal Health Care Private Limited.
- 2021: The company’s subsidiary, Park Medicity India Private Limited acquired Narsingh Hospital & Heart Institute Private Limited.
- 2022: The company’s subsidiary, Park Medicenters & Institutions Private Limited acquired Ratangiri Innovations Private Limited.
- 2023: The company’s subsidiary, Park Medicenters & Institutions Private Limited acquired R G S Healthcare Limited.
- 2025: The company’s subsidiary, Aggarwal Hospitals and Research Services Private Limited acquired 55.00% share capital Devina Derma Private Limited.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
